As of Nov 22
| +0.10 / +0.25%|
The 15 analysts offering 12-month price forecasts for Imperva Inc have a median target of 54.00, with a high estimate of 61.00 and a low estimate of 39.00. The median estimate represents a +33.17% increase from the last price of 40.55.
The current consensus among 18 polled investment analysts is to Buy stock in Imperva Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.